|
|
|
|
|||||
|
|
|
Here are three stocks with buy rank and strong value characteristics for investors to consider today, Dec. 18:
Kimball Electronics, Inc. KE: This company that provides electronics manufacturing and contract manufacturing services for automotive, medical, and industrial markets carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days.
Kimball Electronics, Inc. price-consensus-chart | Kimball Electronics, Inc. Quote
Kimball has a price-to-earnings ratio (P/E) of 21.53, compared with 24.96 for the S&P 500. The company possesses a Value Score of A.
Kimball Electronics, Inc. pe-ratio-ttm | Kimball Electronics, Inc. Quote
Collegium Pharmaceutical, Inc. COLL: This specialty pharmaceutical company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.6% over the last 60 days.
Collegium Pharmaceutical, Inc. price-consensus-chart | Collegium Pharmaceutical, Inc. Quote
Collegium has a price-to-earnings ratio (P/E) of 6.45, compared with 24.96 for the S&P 500. The company possesses a Value Score of A.
Collegium Pharmaceutical, Inc. pe-ratio-ttm | Collegium Pharmaceutical, Inc. Quote
James River Group Holdings, Ltd. JRVR: This specialty insurance company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.5% over the last 60 days.
James River Group Holdings, Ltd. price-consensus-chart | James River Group Holdings, Ltd. Quote
James River has a price-to-earnings ratio (P/E) of 6.30, compared with 8.90 for the industry. The company possesses a Value Score of B.
James River Group Holdings, Ltd. pe-ratio-ttm | James River Group Holdings, Ltd. Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| 4 hours | |
| 6 hours | |
| 13 hours | |
| 13 hours | |
| Dec-17 | |
| Dec-16 | |
| Dec-15 | |
| Dec-14 | |
| Dec-11 | |
| Dec-11 | |
| Dec-11 | |
| Dec-09 | |
| Dec-09 | |
| Dec-07 | |
| Dec-04 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite